Private Equity Firms Rochester NY: Top Firms in 2026

Key Facts: Rochester and Upstate NY Private Equity

• Six to eight PE and venture capital firms are headquartered in or focused on the Rochester and Upstate New York region as of 2025.
• Cephas Capital Partners has deployed more than $115 million in subordinated debt to 65 small businesses since 1997, supporting 6,600 jobs and generating roughly $1 billion in annual regional economic output.
• Fund sizes in this market range from $1.5 million per individual Excell VC check to $152.25 million for Peloton Equity Fund II, which closed in February 2021.
• Dominant strategies span SBA-licensed subordinated debt, healthcare growth equity, lower middle market buyout, private credit, and early-stage venture capital.
• Rochester anchors most local activity, with firms also based in Pittsford, New York City, Greenwich CT, and Syracuse.
• SUNY launched a $6 million Upstate Biotech Ventures fund in July 2024, expanding institutional capital for regional biotech and medical innovation.
• Healthcare IT, medical devices, biotech, advanced manufacturing, and branded consumer products attract the majority of local private equity investment.

Rochester and Upstate NY PE Market Overview

Rochester has a genuine and active private equity ecosystem, not a scaled-down version of what New York City offers. The private equity firms in Rochester NY operate primarily in the lower middle market. Check sizes range from $500,000 for Cephas Capital subordinated debt to $50 million or more in growth equity and buyout transactions.

Regional fund managers rely on the SBA's SBIC leverage program, New York State Empire State Development grants, and a network of community bank limited partners. Rochester's economy provides durable deal flow across several distinct sectors. The city's legacy in optics, photonics, and imaging technology feeds advanced manufacturing and technology spinouts that remain underserved by national PE funds.

The University of Rochester and Rochester Institute of Technology generate life sciences, software, and engineering ventures. Excell serves as the formal university-to-market capital bridge for high-tech startups across the Finger Lakes region. Geographic scope extends beyond Rochester's city limits, with Western NY (Buffalo), the Finger Lakes, Syracuse, and Albany all falling within the regional PE investment frame.

Armory Square Ventures covers Upstate NY from its Syracuse base; Bluehenge Capital Partners targets rural and underserved areas including Upstate NY specifically. Local relationship networks and sector expertise matter more here than brand name. Fund managers can source founder-led businesses at valuations that NYC mega-funds have largely bypassed.

Firm Comparison at a Glance

The following firms represent the core of the Rochester and Upstate New York PE landscape, spanning five distinct strategies and six sector concentrations.

Boathouse Capital and Peloton both operate nationally but have confirmed Rochester-area deal histories. Cephas and Excell are the most purely regional investors, with explicit Upstate NY mandates embedded in their investment thesis.

Top Picks by Investment Strategy

Strongest SBIC Subordinated Debt Lender: Cephas Capital Partners has deployed $115 million to 65 Upstate NY small businesses over 28 years, with individual checks of $500,000 to $4.5 million backed by SBA leverage up to twice the private capital committed.

Healthcare Growth Equity Leader: Peloton Equity targets healthcare companies with $10 to $200 million in revenue and has completed 26 exits including five IPOs. Its largest exit was the $1.1 billion AdaptHealth acquisition of AeroCare Holdings in 2021.

Top Branded Consumer Investor: Twin Lakes Capital holds control and growth positions in premium brands including MacKenzie-Childs, Sergio Tacchini, and Jay Strongwater, operating from dual Rochester and New York City offices.

University-Backed Early Stage VC: Excell invests up to $1.5 million per round in Finger Lakes and New York State high-tech companies, with an explicit mandate to back minority and women-owned ventures in medical devices, biotech, and agtech.

Largest Lower Middle Market Buyout Team: Boathouse Capital has completed more than 100 transactions and deployed $1.5 billion as a team, specializing in Software/SaaS and healthcare IT at the growth and buyout stages.

Most Active Regional Seed Fund: Armory Square Ventures covers Upstate New York from its Syracuse base, ranking among the top-performing PE funds under $250 million by net internal rate of return (IRR). Portfolio companies include ACV Auctions and BentoBox.

Rural and Underserved Capital Provider: Bluehenge Capital Partners has invested $350 million across 46 investments using hybrid debt and equity structures for companies with $20 to $250 million in revenue in underserved regions including Upstate NY.

Top Firms in Detail

Cephas Capital Partners

The primary regional subordinated debt lender for Upstate New York small businesses, Cephas Capital has backed more than 65 companies since 1997, deploying $115 million through mezzanine financing. Its SBA-licensed SBIC structure, approved for Fund III in September 2020, provides access to SBA leverage up to twice its private capital. That structure converts $15 million in LP commitments into $45 million in total funding capacity.

Those limited partners are exclusively regional community banks: Canandaigua National Bank, Five Star Bank, Genesee Regional Bank, NBT Bancorp, Tompkins Trust Company, and four others. This alignment ties investor returns directly to Upstate NY economic outcomes. Cephas deploys $500,000 to $4.5 million per deal in businesses that cannot be fully served by traditional bank lending.

Its portfolio companies employ 6,600 people and contribute approximately $1 billion annually to regional economic output. For Upstate NY owner-operators seeking non-dilutive subordinated debt below $5 million, Cephas has no peer in this geography.

Peloton Equity

Twenty-six exits including five initial public offerings establish Peloton Equity as the most proven healthcare growth equity investor with documented Rochester-area activity. The Greenwich, CT-based firm targets post-venture healthcare companies with $10 to $200 million in revenue. It deploys capital to accelerate growth rather than engineer leverage.

Peloton's Rochester connection runs through AeroSafe Global. The firm backed this cold-chain pharmaceutical packaging company with $31.5 million in 2019 and again in a $43 million round in 2023. Its $152.25 million Fund II closed in February 2021, and recent portfolio additions include Ria Health (telehealth alcohol use disorder treatment, 2025) and OnPoint Healthcare Partners (AI-enabled practice management, 2024).

Peloton Nation, the firm's network of 200 trusted healthcare leaders, contributes an average of nine experts per portfolio company during due diligence and post-investment. Healthcare founders with a technology-enabled service model generating $10 million or more in annual revenue fit this investment thesis precisely.

Twin Lakes Capital

The strategic bridge between Rochester's founder ecosystem and New York City capital markets, Twin Lakes Capital operates from offices in both cities and focuses on branded consumer products, media, and business services. The firm takes both control positions and minority growth equity stakes, giving founders flexibility on transaction structure. Its portfolio includes MacKenzie-Childs (decorative homeware), Sergio Tacchini (Italian sportswear), Jay Strongwater (luxury collectibles), Guide Beauty, and RM Auctions.

This concentration in premium consumer and lifestyle brands distinguishes Twin Lakes from every other PE investor in the Rochester market. No fund size has been publicly disclosed. The quality and national profile of its portfolio companies indicate meaningful check capacity for the right consumer brand acquisition or recapitalization.

Excell

Rochester's university-to-market VC conduit, Excell emerged from a 2006 partnership between the University of Rochester and New York State Empire State Development. This structure gives it both institutional deal flow and a regional economic development mandate. It invests up to $1.5 million per round in early-stage high-tech companies across medical devices, biotech, agtech, imaging, IT, and software, with typical checks of approximately $1 million.

Its explicit priority for minority and women-owned ventures is unique among all PE and VC investors active in the regional market. Excell provides portfolio companies with access to the University of Rochester's professional, corporate, and government networks across New York State, not just capital. Startups in the Finger Lakes region with technology addressing healthcare, life sciences, or advanced agriculture have a direct path to funding through Excell's pitch process.

Graywood Companies

Rochester-headquartered Graywood Companies has assembled a deal history spanning hundreds of acquisitions across industrial distribution, manufacturing, hospitality, retail, real estate, printing, and services. Its generalist investment thesis covers buyouts, growth equity, and business recapitalizations. This makes Graywood the regional firm most suited to family-owned Upstate NY businesses navigating succession planning, estate transitions, or corporate divestitures.

Graywood also operates as a global investor, sourcing transactions beyond Upstate NY when industrial or manufacturing opportunities arise. The firm has not publicly disclosed fund size or assets under management. Industrial manufacturers and service businesses in Monroe County seeking a control investment with deep local sector knowledge should evaluate Graywood first.

Boathouse Capital

Boathouse Capital has completed more than 100 transactions and deployed $1.5 billion as a team. This makes it one of the most active lower middle market buyout firms in Software/SaaS and healthcare IT. The firm uses flexible debt and equity structures tailored to each company's operational needs rather than a fixed leverage formula.

Portfolio companies have included Accurate Background, TapClicks, WillowTree, and Wilkins Media. Boathouse exited both Ontraport and Versalinx in 2025, demonstrating continued portfolio velocity. Software and healthcare IT founders at the growth or buyout stage need an operationally engaged partner, and Boathouse's track record and capital flexibility set it apart from firms that prioritize deal-making over post-investment support.

Armory Square Ventures

Armory Square Ventures ranks among the highest-performing regional seed funds in Upstate New York by documented IRR metrics. The Syracuse-based fund invests across Upstate NY, the Northeast, and the Midwest. Its portfolio includes ACV Auctions, BentoBox, and Good Uncle, spanning auto industry marketplaces, restaurant technology, and consumer food delivery.

The fund focuses on B2B SaaS, enterprise applications, FinTech, and food and agriculture technology. These sectors align directly with Upstate NY's manufacturing, agtech, and university ecosystems. Ranking 6th among top-performing PE and VC funds under $250 million by net IRR has drawn LP interest well beyond the regional market.

Tech entrepreneurs in Rochester with B2B software or agtech products at the seed stage have a natural audience in Armory Square Ventures. Founders here can access top-quartile VC capital without pitching in New York City first.

Trillium Group

Trillium Group invests exclusively in western New York, with 10 of its 14 New York State investments concentrated in the Rochester area. This geographic commitment makes it the most locally focused VC firm in the market. Its sector coverage of life sciences, healthtech, biotechnology, medical devices, and software maps directly to the University of Rochester and RIT research pipelines.

Portfolio companies include VirtualScopics, iCardiac Technologies, and ClearMomentum, all Rochester-area ventures addressing medical imaging and cardiovascular technology. No fund size is publicly disclosed. Unlike Armory Square Ventures, Trillium does not extend its reach into the broader Midwest or national deal flow, making it the most regionally committed general partner in this peer group.

Investment Trends Shaping Rochester and Upstate NY Private Equity

Healthcare Technology Consolidation

Healthcare services remain the dominant capital flow in this regional PE landscape. Peloton Equity alone has made 35 or more healthcare investments across post-acute care, cold-chain pharmaceuticals, AI-enabled practice management, and telehealth. U.S. healthcare's fragmentation continues to create lower middle market acquisition targets, with companies reaching $10 to $50 million in revenue becoming natural consolidation candidates for larger health systems.

AeroSafe Global's progression from a $31.5 million Peloton investment in 2019 to a $43 million follow-on round in 2023 illustrates how capital compounds within this thesis.

SBIC-Enabled Small Business Lending

The SBA Small Business Investment Company program has become a structural amplifier for regional PE deployment. Cephas Capital Fund III converted $15 million in community bank LP capital into $45 million in total funding capacity through SBA leverage. This model aligns private capital returns with local economic development objectives in a way that national buyout funds cannot replicate.

The structure enables $500,000 to $4.5 million subordinated debt transactions. This check size falls below most institutional PE minimums but matches Upstate NY's predominantly lower middle market business base.

University-to-Market Venture Infrastructure

SUNY's 2024 launch of a $6 million Upstate Biotech Ventures fund at SUNY Upstate Medical University adds formal institutional capital to an already established university-to-market pipeline. Excell has operated this infrastructure at the University of Rochester since 2006; the SUNY initiative replicates the model at the system level. Rochester's photonics, optics, and medical device heritage generates ongoing IP commercialization opportunities.

Rochester Institute of Technology contributes engineering and software spinouts alongside the University of Rochester's life sciences pipeline, sustaining a two-institution deal flow that few regional markets can match.

Branded Consumer Brand Consolidation

Twin Lakes Capital's portfolio of MacKenzie-Childs, Jay Strongwater, Sergio Tacchini, and Guide Beauty reflects a deliberate buy-and-build thesis in premium consumer brands. Each portfolio company shares a common profile: established brand equity, loyal consumer bases, and room for operational improvement or distribution expansion. This consolidation approach is unusual in a market otherwise dominated by industrial and technology transactions.

Twin Lakes sources deals across both the Rochester founder community and the broader New York City consumer brand market. This dual pipeline gives the firm a structural sourcing advantage unavailable to purely regional investors.

Private Credit Expansion in the Lower Middle Market

Private credit has become an increasingly accessible capital layer for Upstate NY's lower middle market, sitting between traditional bank debt and institutional equity. National direct lenders now offer products ranging from venture debt and mezzanine financing to collateralized loan obligations and structured credit. This expansion has widened options for companies with $5 to $50 million in revenue that exceed bank underwriting standards but fall below institutional buyout thresholds.

Publicly traded business development companies (BDCs) give retail and institutional investors direct exposure to private credit returns through liquid public market vehicles, complementing the closed-end fund structures that dominate the Rochester PE landscape.

How to Evaluate Rochester and Upstate NY PE Firms

Exit data is the most reliable evaluation metric. Peloton Equity's 26 verified exits including five IPOs provide auditable proof of value creation across healthcare growth equity. Cephas Capital's 65 funded companies over 28 years document a sustained subordinated debt track record, even if individual exit terms are unpublished.

Request exit-level data during due diligence, not just current portfolio lists. Fund size relative to target deal size determines how seriously a firm will prioritize your company. General partners cannot realistically focus on investments outside their optimal check size range without compromising returns to limited partners.

Cephas Fund III's $45 million capacity is optimized for $500,000 to $4.5 million checks. Peloton Fund II's $152 million targets companies with $10 to $200 million in revenue. For LPs evaluating these funds, Cephas Capital's community bank LP base is a meaningful signal.

Regional banks including Five Star Bank and Canandaigua National Bank conduct independent credit assessments before committing LP capital to Cephas. This process reduces adverse selection risk in the portfolio. Armory Square Ventures' documented top-quartile IRR among sub-$250 million funds provides a quantitative starting point for institutional LPs building Upstate NY venture exposure.

Sector specialization is not optional for healthcare companies. Peloton's 200-member professional network averages nine industry experts per portfolio company during due diligence. A generalist fund cannot replicate that operational depth, and founders should weigh the post-investment support network as carefully as the capital valuation.

Which Firm Fits Your Needs?

Upstate NY business owners with $2 to $10 million in revenue needing growth capital beyond bank lending should start with Cephas Capital Partners. Its $500,000 to $4.5 million subordinated debt checks are designed precisely for this scenario. The Pittsford-based team brings 28 years of regional relationship history to every transaction.

Business owners planning succession, an estate recapitalization, or a management buyout should also evaluate Graywood Companies. The firm has completed hundreds of control acquisitions across industrial and service businesses throughout Upstate NY.

Healthcare founders with $10 million or more in annual revenue and a technology-enabled service model should engage Peloton Equity first. Its 35-plus portfolio investments, 26 exits, and 200-member industry network give it capabilities no other Rochester-connected firm can match in healthcare. Branded consumer product companies seeking both capital and sector expertise will find Twin Lakes Capital's dual Rochester and NYC presence a natural fit, with a portfolio of premium lifestyle brands that offers depth unavailable elsewhere in this market.

Early-stage tech founders at the University of Rochester or in the Finger Lakes region should approach Excell before seeking capital outside the region. Its $1 million average check and hands-on support make it the most accessible first institutional capital source locally. Excell explicitly prioritizes minority and women-owned ventures, a distinction no other regional PE or VC investor offers.

LPs seeking documented Upstate NY venture returns should note Armory Square Ventures' top-quartile IRR ranking among sub-$250 million PE funds. This is one of the few publicly verifiable performance data points available in the regional market.

Methodology

This guide to private equity firms in Rochester NY was compiled using publicly available firm disclosures, fund announcements, press releases, and SEC filings through early 2026. Firm selection required either a headquarters location in Rochester or Upstate New York, or documented investment activity in Rochester-area portfolio companies. Fund sizes and capital deployment figures come directly from firm disclosures; where no public figure is available, the relevant field is marked accordingly. Deal data reflects announcements through Q1 2026. This article does not constitute investment advice or an endorsement of any firm.